Peripheral arterial disease: diagnosis and management
KEYWORDS: people, disease, peripheral arterial, peripheral, arterial, arterial disease, limb, critical, critical limb, pain, diabetes, treating, exercise, claudication, ischaemia

advice, support and treatment regarding the secondary prevention of cardiovascular disease, in line with published NICE guidance on: • treating tobacco dependence • diet, weight management and exercise • lipid modification and statin therapy • diabetes • high blood pressure • antiplatelet therapy. [2012] 1.2.2 Rivaroxaban plus aspirin is recommended as an option in NICE technology appraisal guidance for preventing atherothrombotic events in people with symptomatic peripheral arterial disease at high risk of ischaemic events. For full details, see the guidance on rivaroxaban (TA607, 2019). 1.2.3 Clopidogrel is recommended as an option in NICE technology appraisal guidance for preventing occlusive vascular events in people with peripheral arterial disease. For full details, see the guidance on clopidogrel (TA210, 2010). 1.3 Diagnosis 1.3.1 Assess people for the presence of peripheral arterial disease if they: • have symptoms suggestive of peripheral arterial disease or • have diabetes, non-healing wounds on the legs or feet, or unexplained leg pain or • are being considered for interventions to the leg or foot or • need to use compression hosiery. [2012] 1.3.2 Assess people with suspected peripheral arterial disease by: • asking about the presence and severity of possible symptoms of intermittent claudication and critical limb
